Canada
· Delayed Price · Currency is CAD Nova Leap Health Statistics
Total Valuation
Nova Leap Health has a market cap or net worth of CAD 21.98 million. The enterprise value is 21.75 million.
| Market Cap | 21.98M |
| Enterprise Value | 21.75M |
Important Dates
The last earnings date was Friday, November 8, 2024.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Nova Leap Health has 86.21 million shares outstanding. The number of shares has decreased by -0.02% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 86.21M |
| Shares Change (YoY) | -0.02% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 20.81% |
| Owned by Institutions (%) | n/a |
| Float | 50.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.63 |
| PB Ratio | 0.88 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -34.81 |
| EV / Sales | 0.63 |
| EV / EBITDA | 10.15 |
| EV / EBIT | 16.76 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.06.
| Current Ratio | 1.76 |
| Quick Ratio | 1.60 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.75 |
| Debt / FCF | n/a |
| Interest Coverage | 12.87 |
Financial Efficiency
Return on equity (ROE) is -2.49% and return on invested capital (ROIC) is 2.97%.
| Return on Equity (ROE) | -2.49% |
| Return on Assets (ROA) | 2.79% |
| Return on Capital (ROIC) | 2.97% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.19 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.87% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +10.87% |
| 50-Day Moving Average | 0.27 |
| 200-Day Moving Average | 0.27 |
| Relative Strength Index (RSI) | 37.30 |
| Average Volume (20 Days) | 29,415 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Nova Leap Health had revenue of CAD 34.76 million and -624,756 in losses. Loss per share was -0.01.
| Revenue | 34.76M |
| Gross Profit | 13.40M |
| Operating Income | 1.30M |
| Pretax Income | -648,252 |
| Net Income | -624,756 |
| EBITDA | 1.67M |
| EBIT | 1.30M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 1.84 million in cash and 1.60 million in debt, giving a net cash position of 233,645 or 0.00 per share.
| Cash & Cash Equivalents | 1.84M |
| Total Debt | 1.60M |
| Net Cash | 233,645 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 24.85M |
| Book Value Per Share | 0.29 |
| Working Capital | 1.95M |
Cash Flow
| Operating Cash Flow | 2.17M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 38.56%, with operating and profit margins of 3.73% and -1.80%.
| Gross Margin | 38.56% |
| Operating Margin | 3.73% |
| Pretax Margin | -1.87% |
| Profit Margin | -1.80% |
| EBITDA Margin | 4.80% |
| EBIT Margin | 3.73% |
| FCF Margin | n/a |
Dividends & Yields
Nova Leap Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.02% |
| Shareholder Yield | 0.02% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Nova Leap Health has an Altman Z-Score of 4.89.
| Altman Z-Score | 4.89 |
| Piotroski F-Score | n/a |